Literature DB >> 24154605

Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells.

Minjun Cao1, Xiongwei Deng, Shishuai Su, Fang Zhang, Xiangqian Xiao, Qin Hu, Yongwei Fu, Burton B Yang, Yan Wu, Wang Sheng, Yi Zeng.   

Abstract

We report an innovative approach for miRNA-203 delivery in esophageal cancer cells using protamine sulphate (PS)-nanodiamond (ND) nanoparticles. The efficient delivery of miR-203 significantly suppressed the proliferation and migration of cancer cells through targeting Ran and ΔNp63, exhibiting a great potential for PS@ND nanoparticles in miRNA-based cancer therapy.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24154605     DOI： 10.1039/c3nr04056a

Source DB:  PubMed          Journal:  Nanoscale        ISSN： 2040-3364            Impact factor:   7.790


  11 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

2.  The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.

Authors:  Huilin Zhang; Yuan Mao; Feng Zhang; Chunping Ye; Hua Tong; Yiping Su; Jin Zhu
Journal:  Mol Cell Biochem       Date:  2014-02-25       Impact factor: 3.396

Review 3.  Non-coding RNAs and potential therapeutic targeting in cancer.

Authors:  Shusuke Toden; Timothy J Zumwalt; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-13       Impact factor: 10.680

Review 4.  The microRNA feedback regulation of p63 in cancer progression.

Authors:  Changwei Lin; Xiaorong Li; Yi Zhang; Yihang Guo; Jianyu Zhou; Kai Gao; Jing Dai; Gui Hu; Lv Lv; Juan Du; Yi Zhang
Journal:  Oncotarget       Date:  2015-04-20

5.  Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.

Authors:  Rammohan Devulapally; Narayana M Sekar; Thillai V Sekar; Kira Foygel; Tarik F Massoud; Jürgen K Willmann; Ramasamy Paulmurugan
Journal:  ACS Nano       Date:  2015-02-23       Impact factor: 15.881

6.  MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.

Authors:  Shao-Jun Chu; Ge Wang; Peng-Fei Zhang; Rui Zhang; Yan-Xia Huang; Yun-Min Lu; Wei Da; Qun Sun; Jing Zhang; Jin-Shui Zhu
Journal:  J Exp Clin Cancer Res       Date:  2016-03-15

Review 7.  Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.

Authors:  Ming Ming Wen
Journal:  Front Mol Neurosci       Date:  2016-11-22       Impact factor: 5.639

8.  Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment.

Authors:  Li Zhang; Mengchu Yao; Wei Yan; Xiaoning Liu; Baofei Jiang; Zhaoye Qian; Yong Gao; Xiao-Jie Lu; Xiaofei Chen; Qi-Long Wang
Journal:  Int J Nanomedicine       Date:  2017-09-11

Review 9.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

Review 10.  Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.

Authors:  Bidisha Roy; Erica Lee; Teresa Li; Maria Rampersaud
Journal:  Genes (Basel)       Date:  2022-02-25       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.